High Cost of Weight Loss Drugs in the US Compared to Other Countries: Analysis Reveals
A new analysis from KFF reveals that weight loss drugs like Ozempic, Wegovy, and Mounjaro are significantly more expensive in the U.S. compared to other wealthy nations, with the list price being up to 10 times lower in some countries. For example, a one-month supply of Ozempic costs $936 in the U.S., while no other country paid more than $200 for the same drug. The U.S. also paid about four times more for Wegovy compared to the Netherlands and Germany. The analysis highlights the high rate of obesity in the U.S. and the challenges of getting these drugs covered by insurance. Lawmakers have reintroduced the Treat and Reduce Obesity Act to expand Medicare coverage for weight loss services and medications.
- The US pays more for newer weight loss drugs than its peers: report The Hill
- Weight-loss drugs are priced substantially higher in the U.S. than in other countries, analysis says CNBC
- Weight loss and diabetes drugs cost more in the US than in other countries, KFF analysis finds CNN
- Ozempic, Wegovy, Mounjaro Are More Expensive in US Than in Other Countries Bloomberg
Reading Insights
0
1
2 min
vs 3 min read
79%
577 → 120 words
Want the full story? Read the original article
Read on The Hill